Category : Search result: Semaglutide


New Medical Uses for Weight-Loss Drugs Revealed

Explore how drugs like Ozempic and Wegovy are being tested for conditions from Alzheimer's to sleep apnea, despite a recent trial setback. Discover the future of GLP-1 treatments.

Novo Nordisk Alzheimer's drug trial fails

A major study testing Novo Nordisk's semaglutide for Alzheimer's disease has failed, dealing a blow to hopes of a new treatment for over 55 million patients. Discover the full story.

Novo Nordisk Alzheimer's Drug Trial Fails

Novo Nordisk's major Alzheimer's drug trial fails to show significant benefit, dashing hopes for a fast-tracked treatment. Read the full analysis of this setback.

Trump Pressures Novo Nordisk Over Ozempic Pricing

Former President Donald Trump is reportedly pushing pharmaceutical giant Novo Nordisk for major Ozempic price cuts in a move that could transform diabetes and weight loss treatment accessibility in America.

Prue Leith: Weight loss jabs didn't work for me

Great British Bake Off star Prue Leith, 85, reveals her surprising experience with weight loss injections, detailing how she lost her appetite but failed to drop any weight while battling exhausting energy slumps.

Anorexic woman nearly dies from weight loss jab

UK doctors issue urgent safety warning after severely anorexic woman nearly dies from popular diabetes medication being used for weight loss. Exclusive medical case study reveals critical risks.

Dangerous Weight Loss Drugs Flood UK Market

Exclusive investigation reveals dangerous counterfeit weight loss medications are being illegally sold across Britain, putting thousands at risk of serious health complications.

Weight Loss Injections Cut Heart Attack Risk

Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.

New mothers risking health for wedding weight loss

Alarming numbers of UK new mothers are turning to weight-loss injections to achieve 'wedding body' goals, with some reporting severe side effects and dangerous mental health consequences.

Academics Urge Lower BMI for Wegovy Access

University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.

Weight loss jabs boost heart health, study finds

Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.

Weight loss jabs slash heart risk in UK study

Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.

Wegovy Gains Medicaid Coverage in US States

Groundbreaking obesity medication Wegovy gains Medicaid coverage across multiple American states, marking a significant shift in healthcare policy for weight management treatments.

Urgent alert over fake weight loss drugs in UK

Health authorities issue critical warning about counterfeit Ozempic injections found in the UK, posing severe health risks including hospitalisation. Essential safety information for consumers.

Fake weight-loss jabs warning: Counterfeits sold online

Dangerous fake versions of Ozempic and other weight-loss injections are being sold illegally online, posing severe health risks including hospitalisation. Health authorities warn against purchasing unregulated treatments.

Weight Loss Drugs Linked to Reduced Alcohol Cravings

Groundbreaking research reveals GLP-1 medications prescribed for weight management are showing unexpected benefits in reducing alcohol consumption among users, with some reporting complete loss of interest in drinking.

Wegovy and Mounjaro Weight Loss Jabs Available in UK

Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.

Page 1 of 4